( This analysis is a short recap from a more extensive deep dive that I have published [here.](https://open.substack.com/pub/melifinance/p/kumulus-vape-sa-a-tiny-beauty-being?r=84zv6&utm_campaign=post&utm_medium=web&showWelcomeOnShare=true))
Market Cap €8.9M
Shares Outstanding 3.02M
52-Wk Range (est.) €2.40 – €4.80
EPS FY2025 €0.33
P/E (TTM) 8.9×
Price / NCAV 0.72×
Price / TBV 0.63×
Net Cash +€3.0M
Insider Ownership 37%
dividend: 3.4%
Kumulus Vape S.A. (EPA: ALVAP) presents a classic micro-cap contrarian setup that fits Benjamin Graham's "net-net" or a Walter Schloss-style deep tangible asset play. As of mid-June 2026, the stock trades at approximately €2.93, with a market capitalization of €8.9M, amid compressed earnings, intense regulatory scrutiny in the European vaping sector, and unregulated Chinese competition.
The catalyst: Execs skin in the Game.
"Uglystock investing" goes beyond simple valuation; the story factor is even more important. If a stock's story doesn't grab my attention immediately, I rarely take a second look and move on. That wasn't exactly the case with this tiny company. I wasn't exactly blindsighted, but I found its story intriguing enough to make me "wanna know more."
What I discovered was quite exciting: a passionate founder and CEO, supported by a strong team that has worked together since the company's inception.
Founder/CEO Rémi Baert (a self-made entrepreneur) and the team (including CFO Laetitia Touchet and COO Lionel Hugues) are true believers with significant skin in the game. They collectively hold a substantial portion (37%, according to some shareholder breakdowns). Alignment is clear, as insiders face the same challenges and upside. The company has conducted share buybacks and capital reductions amid the downturn and pays dividends, signaling a focus on capital returns.
**Vaping goes beyond a mere business for these folks; the business was developed as an outlet for a group of former smokers wanting to combat traditional tobacco nicotine addiction.**
* The retailer boasts an outstanding 4.9 out of 5-star rating on independent, verified platforms like [Trustpilot](https://fr.trustpilot.com/review/kumulusvape.fr).
* Buyers frequently note that orders are shipped promptly, often with small complimentary gifts added to packages.
* Beyond retail, the company is actively engaged in promoting the use of e-cigarettes as a recognized smoking cessation tool, frequently commissioning independent health surveys regarding vaping efficacy.
The fundamental principles of good management are clear: ethical, skin in the Game, honest leadership that strives for more than just profit.
The company grew from these values rather than forcing its way into the market. It's often much easier when natural market demand drives the product than when it doesn't.
Though the story seems small and insignificant given the company's size and market cap, in business, size isn’t everything.
**Great businesses are defined by their quality, story, and value, not solely by scale. When employees and executives enjoy their work doing something they find important and meaningful, I want to be part of that journey and share in its success as a shareholder.**
# The Ugly:
Despite carving out a competitive niche in France via compliance transparency and customer education, the company is battling structural and cyclical headwinds:
* Product Shift: A structural market shift from premium refillables to low-margin disposable vapes.
* Macro Pressures: Regulatory tightening across the EU and aggressive price competition from illicit, unauthorized Chinese imports.
* Margin Compression: These dynamics culminated in a challenging FY2025, where revenue fell 5% YoY to €57.5M and gross margins tightened to 14.3%.
The stock peaked at EU14 per share in 2021 and has lost nearly 70% of its value over the past 5 years. This is a hard pill to swallow for a shareholder and a telltale sign of the underlying operational reality on the ground. Clearly, forces are at work that are eroding the company's strategic niche. Maybe large tobacco corporations have decided to enter the field and flood it with competitive alternatives, or the effect of murky EU regulatory complexity on the market, or the unregulated, cheap Chinese platforms. It is really hard to pinpoint a specific issue, but the fact is that "Kumulus" is not a growth story but rather a resilient, passion-driven platform.
**Can it turnaround?**
# The beauty:
Early Q1 2026 data points to revenue stabilization, suggesting that the worst of the operational degradation may be bottoming out.
**Quantitative Valuation: Graham NCAV & Schloss TBV**
To quantify the margin of safety, we strip out all subjective long-term growth assumptions and evaluate Kumulus Vape strictly through a liquidating-asset lens, using audited FY2025 balance sheet data (ended Dec 31, 2025).
Balance Sheet Breakdown (in €M)
* Cash & Cash Equivalents: €6.47M
* Trade Receivables: €7.84M
* Inventory: €8.57M
* Total Current Assets: €22.87M
* Total Assets: €27.52M
* Total Liabilities: €10.57M *(Current Liabilities: €7.9M)*
* Shareholders' Equity: €16.95M
1. Ben Graham Net Current Asset Value (NCAV)
Graham’s NCAV metric measures a company's liquidation value by looking solely at current assets and subtracting all liabilities, treating fixed assets (property, plant, and equipment) and intangibles as completely worthless in a distress scenario.
NCAV=Total Current Assets−Total Liabilities
NCAV=€22.87M−€10.57M=€12.30M
With 3.02M shares outstanding, this translates to an NCAV per share of €4.07. At a current share price of €2.93, Kumulus Vape trades at 0.72x NCAV—representing a massive 28% discount to its net liquidating value.
**While it does not fully breach Graham's ultra-strict rule of trading at less than two-thirds of NCAV (≤0.67x), a 28% discount for a business that remains structurally profitable is a rare anomaly in today's market**.
2. Walter Schloss Tangible Book Value (TBV) Analysis
Legendary value investor Walter Schloss looked for companies trading at deep discounts to tangible book value, backed by clean balance sheets and zero debt.
Kumulus Vape holds a positive Net Cash position of approximately €3.0M and working capital of €14.97M. If we strip away goodwill and intangible assets from total equity, we arrive at a highly conservative Tangible Book Value:
* Tangible Book Value (TBV): \~€14.01M
* TBV Per Share: \~€4.63
* Price / TBV: 0.63x
Buying a company with positive net cash, no long-term solvency threat, and a history of generating free cash flow at just 63% of its physical net worth aligns perfectly with classic deep-value criteria.
# Conclusion: Ugly, Abandoned, yet a Statistically Cheap acquisition premium.
Kumulus Vape is not a compounder. It is not a growth story. It is an ugly stock in a struggling, low-barrier-to-entry industry operating in a deteriorating regulatory environment, with earnings that have collapsed 62% in a single year.
The consensus hates it. The market has ignored it. I disagree!
I see a lot of potential in the company. But the human factor is even more compelling to me.
The founder and his team are truly dedicated to vaping as an alternative to smoking. They are true believers and are building an entire production-to-retail and marketing ecosystem around vaping. That's all I look for in management: integrity and 100% focus. I am looking for a buy-and-forget situation, and in Baert and his team's case, the trust factor is seriously compelling.
**At €2.93, the stock trades at 0.72× NCAV and 0.63× Tangible Book Value, against a backdrop of positive net income and net cash, zero long-term debt, and 37% insider ownership. The bear case is already fully priced in. The upside, even a partial revaluation to NCAV, represents approximately a 39% return from current levels. Moreover, the company has built strong brand equity in its niche and could easily be the target of an attractive acquisition offer from a richer, deep-pocketed European or international distributor looking to consolidate the French vape market.**
